225 related articles for article (PubMed ID: 37298607)
21. Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: regional experience and high incidence of carnitine deficiency.
Couce ML; Sánchez-Pintos P; Diogo L; Leão-Teles E; Martins E; Santos H; Bueno MA; Delgado-Pecellín C; Castiñeiras DE; Cocho JA; García-Villoria J; Ribes A; Fraga JM; Rocha H
Orphanet J Rare Dis; 2013 Jul; 8():102. PubMed ID: 23842438
[TBL] [Abstract][Full Text] [Related]
22. Data mining methods for classification of Medium-Chain Acyl-CoA dehydrogenase deficiency (MCADD) using non-derivatized tandem MS neonatal screening data.
Van den Bulcke T; Vanden Broucke P; Van Hoof V; Wouters K; Vanden Broucke S; Smits G; Smits E; Proesmans S; Van Genechten T; Eyskens F
J Biomed Inform; 2011 Apr; 44(2):319-25. PubMed ID: 21167313
[TBL] [Abstract][Full Text] [Related]
23. Sudden death in medium chain acyl-coenzyme a dehydrogenase deficiency (MCADD) despite newborn screening.
Yusupov R; Finegold DN; Naylor EW; Sahai I; Waisbren S; Levy HL
Mol Genet Metab; 2010 Sep; 101(1):33-9. PubMed ID: 20580581
[TBL] [Abstract][Full Text] [Related]
24. Validation of a targeted metabolomics panel for improved second-tier newborn screening.
Mak J; Peng G; Le A; Gandotra N; Enns GM; Scharfe C; Cowan TM
J Inherit Metab Dis; 2023 Mar; 46(2):194-205. PubMed ID: 36680545
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and mutation analysis of short/branched chain acyl-CoA dehydrogenase deficiency (SBCADD) detected on newborn screening in Wisconsin.
Van Calcar SC; Baker MW; Williams P; Jones SA; Xiong B; Thao MC; Lee S; Yang MK; Rice GM; Rhead W; Vockley J; Hoffman G; Durkin MS
Mol Genet Metab; 2013; 110(1-2):111-5. PubMed ID: 23712021
[TBL] [Abstract][Full Text] [Related]
26. Medium-chain Acyl-COA dehydrogenase deficiency: Pathogenesis, diagnosis, and treatment.
Mason E; Hindmarch CCT; Dunham-Snary KJ
Endocrinol Diabetes Metab; 2023 Jan; 6(1):e385. PubMed ID: 36300606
[TBL] [Abstract][Full Text] [Related]
27. Medium-chain acyl-CoA deficiency: outlines from newborn screening, in silico predictions, and molecular studies.
Catarzi S; Caciotti A; Thusberg J; Tonin R; Malvagia S; la Marca G; Pasquini E; Cavicchi C; Ferri L; Donati MA; Baronio F; Guerrini R; Mooney SD; Morrone A
ScientificWorldJournal; 2013; 2013():625824. PubMed ID: 24294134
[TBL] [Abstract][Full Text] [Related]
28. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) in the UK.
Goddard P
J Fam Health Care; 2004; 14(4):90-2. PubMed ID: 15453442
[TBL] [Abstract][Full Text] [Related]
29. Targeted metabolomics in the expanded newborn screening for inborn errors of metabolism.
Scolamiero E; Cozzolino C; Albano L; Ansalone A; Caterino M; Corbo G; di Girolamo MG; Di Stefano C; Durante A; Franzese G; Franzese I; Gallo G; Giliberti P; Ingenito L; Ippolito G; Malamisura B; Mazzeo P; Norma A; Ombrone D; Parenti G; Pellecchia S; Pecce R; Pierucci I; Romanelli R; Rossi A; Siano M; Stoduto T; Villani GR; Andria G; Salvatore F; Frisso G; Ruoppolo M
Mol Biosyst; 2015 Jun; 11(6):1525-35. PubMed ID: 25689098
[TBL] [Abstract][Full Text] [Related]
30. Metabonomics of newborn screening dried blood spot samples: a novel approach in the screening and diagnostics of inborn errors of metabolism.
Dénes J; Szabó E; Robinette SL; Szatmári I; Szőnyi L; Kreuder JG; Rauterberg EW; Takáts Z
Anal Chem; 2012 Nov; 84(22):10113-20. PubMed ID: 23094949
[TBL] [Abstract][Full Text] [Related]
31. Dissection of biochemical borderline phenotypes in carriers and genetic variants of medium-chain acyl-CoA dehyrogenase deficiency: implications for newborn screening [corrected].
Maier EM; Pongratz J; Muntau AC; Liebl B; Nennstiel-Ratzel U; Busch U; Fingerhut R; Olgemöller B; Roscher AA; Röschinger W
Clin Genet; 2009 Aug; 76(2):179-87. PubMed ID: 19780764
[TBL] [Abstract][Full Text] [Related]
32. A one-year pilot study comparing direct-infusion high resolution mass spectrometry based untargeted metabolomics to targeted diagnostic screening for inherited metabolic diseases.
Willems AP; van der Ham M; Schiebergen-Bronkhorst BGM; van Aalderen M; de Barse MMJ; De Gruyter FE; van Hoek IN; Pras-Raves ML; de Sain-van der Velden MGM; Prinsen HCMT; Verhoeven-Duif NM; Jans JJM
Front Mol Biosci; 2023; 10():1283083. PubMed ID: 38028537
[No Abstract] [Full Text] [Related]
33. Epidemiology of rare diseases detected by newborn screening in the Czech Republic.
David J; Chrastina P; Pešková K; Kožich V; Friedecký D; Adam T; Hlídková E; Vinohradská H; Novotná D; Hedelová M; Al Taji E; Holubová A; Skalická V; Macek M; Gaillyová R; Votava F
Cent Eur J Public Health; 2019 Jun; 27(2):153-159. PubMed ID: 31241292
[TBL] [Abstract][Full Text] [Related]
34. Genotype and residual enzyme activity in medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Are predictions possible?
Tucci S; Wagner C; Grünert SC; Matysiak U; Weinhold N; Klein J; Porta F; Spada M; Bordugo A; Rodella G; Furlan F; Sajeva A; Menni F; Spiekerkoetter U
J Inherit Metab Dis; 2021 Jul; 44(4):916-925. PubMed ID: 33580884
[TBL] [Abstract][Full Text] [Related]
35. Studying Autism Using Untargeted Metabolomics in Newborn Screening Samples.
Courraud J; Ernst M; Svane Laursen S; Hougaard DM; Cohen AS
J Mol Neurosci; 2021 Jul; 71(7):1378-1393. PubMed ID: 33515432
[TBL] [Abstract][Full Text] [Related]
36. Targeted Metabolomics Reveals Birth Screening Biomarkers for Biliary Atresia in Dried Blood Spots.
Xiao Y; Zhou Y; Zhou K; Cai W
J Proteome Res; 2022 Mar; 21(3):721-726. PubMed ID: 34850627
[TBL] [Abstract][Full Text] [Related]
37. Novel mutations causing medium chain acyl-CoA dehydrogenase deficiency: under-representation of the common c.985 A > G mutation in the New York state population.
Nichols MJ; Saavedra-Matiz CA; Pass KA; Caggana M
Am J Med Genet A; 2008 Mar; 146A(5):610-9. PubMed ID: 18241067
[TBL] [Abstract][Full Text] [Related]
38. Ethnicity of children with homozygous c.985A>G medium-chain acyl-CoA dehydrogenase deficiency: findings from screening approximately 1.1 million newborn infants.
Khalid JM; Oerton J; Cortina-Borja M; Andresen BS; Besley G; Dalton RN; Downing M; Green A; Henderson M; Leonard J; Dezateux C;
J Med Screen; 2008; 15(3):112-7. PubMed ID: 18927092
[TBL] [Abstract][Full Text] [Related]
39. Prediction of VLCAD deficiency phenotype by a metabolic fingerprint in newborn screening bloodspots.
Knottnerus SJG; Pras-Raves ML; van der Ham M; Ferdinandusse S; Houtkooper RH; Schielen PCJI; Visser G; Wijburg FA; de Sain-van der Velden MGM
Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165725. PubMed ID: 32061778
[TBL] [Abstract][Full Text] [Related]
40. The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005.
Frazier DM; Millington DS; McCandless SE; Koeberl DD; Weavil SD; Chaing SH; Muenzer J
J Inherit Metab Dis; 2006 Feb; 29(1):76-85. PubMed ID: 16601872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
